Coupling of L-type voltage-sensitive calcium channels to P2X(2) purinoceptors in PC-12 cells

Am J Physiol Cell Physiol. 2001 May;280(5):C1121-9. doi: 10.1152/ajpcell.2001.280.5.C1121.

Abstract

Extracellular ATP elevates cytosolic Ca(2+) by activating P2X and P2Y purinoceptors and voltage-sensitive Ca(2+) channels (VCCCs) in PC-12 cells, thereby facilitating catecholamine secretion. We investigated the mechanism by which ATP activates VSCCs. 2-Methylthioadenosine 5'-triphosphate (2-MeS-ATP) and UTP were used as preferential activators of P2X and P2Y, respectively. Nifedipine inhibited the ATP- and 2-MeS-ATP-evoked cytosolic Ca(2+) concentration increase and [(3)H]norepinephrine secretion, but not the UTP-evoked responses. Studies with Ca(2+) channel blockers indicated that L-type VSCCs were activated after the P2X activation. Mn(2+) entry profiles and studies with thapsigargin revealed that Ca(2+) entry, rather than Ca(2+) release, was sensitive to nifedipine. Although P2X(2) and P2X(4) receptor mRNAs were detected, studies with pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid revealed that P2X(2) was mainly coupled to the L-type VSCCs. The inhibitory effect of nifedipine did not occur in the absence of extracellular Na(+), suggesting that Na(+) influx, which induces depolarization, was essential for the P2X(2)-mediated activation of VSCCs. We report that depolarization induced by Na(+) entry through the P2X(2) purinoceptors effectively activates L-type VSCCs in PC-12 cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives*
  • Adenosine Triphosphate / metabolism
  • Adenosine Triphosphate / pharmacology
  • Animals
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology*
  • Calcium Channels, L-Type / physiology*
  • Cell Membrane / physiology
  • Cytosol / metabolism
  • Manganese / metabolism
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • Nifedipine / pharmacology
  • Norepinephrine / metabolism
  • PC12 Cells
  • Protein Isoforms / drug effects
  • Protein Isoforms / genetics
  • Protein Isoforms / physiology
  • Rats
  • Receptors, Purinergic P2 / drug effects
  • Receptors, Purinergic P2 / genetics
  • Receptors, Purinergic P2 / physiology*
  • Receptors, Purinergic P2X2
  • Reverse Transcriptase Polymerase Chain Reaction
  • Thapsigargin / pharmacology
  • Thionucleotides / pharmacology
  • Uridine Triphosphate / pharmacology
  • Verapamil / pharmacology
  • omega-Conotoxin GVIA / pharmacology

Substances

  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Protein Isoforms
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2X2
  • Thionucleotides
  • Manganese
  • Thapsigargin
  • Adenosine Triphosphate
  • omega-Conotoxin GVIA
  • Verapamil
  • Nifedipine
  • Calcium
  • Uridine Triphosphate
  • Norepinephrine
  • 2-methylthio-ATP